Petros Pharmaceuticals, Inc.
(NASDAQ:PTPI)
$1.537
0.08 (5.24%)
At Close: 4:00 PM
PTPI Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
PTPI Stock Price Today
Petros Pharmaceuticals, Inc. (PTPI) stock rallied over 5.24% intraday to trade at $1.5365 a share on NASDAQ. The stock opened with a gain of 6.16% at $1.55 and touched an intraday high of $1.594, rising 5.24% against the last close of $1.46. The Petros Pharmaceuticals, Inc. in stock market went to a low of $1.4 during the session.
PTPI Stock Snapshot
$1.46
Prev. Close
2.64 Million
Market Cap
$1.4
Day Low
$1.55
Open
20.69 Million
Number of Shares
$1.594
Day High
-
P/E ratio
-1.51
EPS (TTM)
5.40
Cash Flow per Share
2.34
Free Float in %
1.82
Book Value
5,172
Volume
Contact Details
1185 Avenue of the Americas
Suite 249
New York, NY 10036
United States
Website:https://www.petrospharma.com
Contact #:973-242-0005
Company Information
Employees24
Beta-
Sales or Revenue$4.33 Million
5Y Sales Change-
Fiscal Year EndsDec. 2021
SectorHealth Care
IndustryPharmaceuticals
About Company
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
Frequently Asked Questions
What is the current Petros Pharmaceuticals, Inc. (PTPI) stock price?
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) stock price is $1.54 in the last trading session. During the trading session, PTPI stock reached the peak price of $1.594 while $1.4 was the lowest point it dropped to. The percentage change in PTPI stock occurred in the recent session was 5.24% while the dollar amount for the price change in PTPI stock was $0.08.
PTPI's industry and sector of operation?
The NASDAQ listed PTPI is part of Pharmaceuticals industry that operates in the broader Health Care sector. Petros Pharmaceuticals, Inc. , a pharmaceutical company, focuses on men's health therapeutics.
Who are the executives of PTPI?
Mr. Mitchell S. Arnold M.B.A.
Vice President of Fin. & Chief Accounting Officer
Mr. John D. Shulman
Executive Chairman
Mr. Fady Boctor M.B.A.
Principal Executive Officer, Pres & Chief Commercial Officer
Mr. John D. Shulman
Exec. Chairman
How PTPI did perform over past 52-week?
PTPI's closing price is 0.14% higher than its 52-week low of $1.321 where as its distance from 52-week high of $28.8 is -0.95%.
How many employees does PTPI have?
Number of PTPI employees currently stands at 24. PTPI operates from 1185 Avenue of the Americas, Suite 249, New York, NY 10036, United States.
Link for PTPI official website?
Official Website of PTPI is: https://www.petrospharma.com
How do I contact PTPI?
PTPI could be contacted at phone #973-242-0005 and can also be accessed through its website. PTPI operates from 1185 Avenue of the Americas, Suite 249, New York, NY 10036, United States.
How many shares of PTPI are traded daily?
PTPI stock volume for the day was 5,172 shares. The average number of PTPI shares traded daily for last 3 months was 18.55 Thousands.
What is the market cap of PTPI currently?
The market value of PTPI currently stands at $2.64 Million with its latest stock price at $1.54 and 20.69 Million of its shares outstanding.